Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052036

Chief Scientific Officer sold 33,300 shares at an average $47.61 ($1,585,430)

  • Chief Scientific Officer acquired 33,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-22 Exercise or conversion : show line 1 in the form +11,100 $6.32 $70,152 11,779 D
2020-09-22 Sale : show line 2 in the form −7,000 $47.34 $331,380 4,779 D
2020-09-22 Sale : show line 3 in the form −4,100 $47.95 $196,595 679 D
2020-09-23 Exercise or conversion : show line 4 in the form +11,100 $6.32 $70,152 11,779 D
2020-09-23 Sale : show line 5 in the form −11,100 $48.16 $534,576 679 D
2020-09-24 Exercise or conversion : show line 6 in the form +11,100 $6.32 $70,152 11,779 D
2020-09-24 Sale : show line 7 in the form −3,640 $46.00 $167,440 8,139 D
2020-09-24 Sale : show line 8 in the form −3,560 $47.28 $168,317 4,579 D
2020-09-24 Sale : show line 9 in the form −3,900 $47.98 $187,122 679 D
Open-market sales · 33,300 sh · avg $47.61 · $1,585,430

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-09-22 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −11,100 322,500 D
2020-09-23 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −11,100 311,400 D
2020-09-24 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −11,100 300,300 D
Loading xslF345X03/doc4.xml…